When present in tumor-bearing individuals, VEGF-A has an immunosuppressive function that can inhibit the antitumor activity of CD8+ T cells within tumors by aggravating the hypoxic microenvironment, activating an exhaustion-specific transcription program and prompting the proliferation and activity of regulatory T cells [28–30]. This evidence concerns the gene VEGFA and neoplasm.